SCHEMBL21620909

SCHEMBL21620909

CNS(=O)(=O)CC(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24074759 1.00
SCHEMBL24075098 1.00
SCHEMBL605797 0.78
SCHEMBL22304295 0.77 TDP1 (0.30)
SCHEMBL24815847 0.75
SCHEMBL18210893 0.74
Dimethylamine SCHEMBL9347103 0.74 SLC22A6 (0.37)
Dimethylamine SCHEMBL28812089 0.74 SLC22A6 (0.37)
SCHEMBL24815825 0.73 POLB (0.30)
Dimethylamine SCHEMBL28954501 0.72 SLC22A6 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219963-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES PFIZER INC. (US) 2023-07-13 US disclosed
WO-2022268230-A1 COMPOUND AS KIF18A INHIBITOR 杭州英创医药科技有限公司 2022-12-29 WO disclosed
WO-2021240356-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES PFIZER INC. (US) 2021-12-02 WO disclosed
US-20200247812-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE INTEGRAL BIOSCIENCES PRIVATE LTD (IN) 2020-08-06 US disclosed
WO-2020012357-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE INTEGRAL BIOSCIENCES PVT. LTD. (IN) 2020-01-16 WO disclosed